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Abstract 20 
Purpose: Improving the understanding of the role of genetic risk on disordered eating (DE). 21 
Methods: A case-control study including 1,757 (F: 979, M: 778) adolescents (aged 13-19 22 
years) from the Nord-Trøndelag Health Study (HUNT), an ethnically homogenous Norwegian 23 
population based study. Cases and controls were defined using a shortened version of the 24 
Eating Attitude Test. Logistic regression was employed to test for associations between DE 25 
phenotypes  and 24 obesity and eating disorder susceptibility SNPs, and the joint effect of a 26 
subset of these in a genetic risk score (GRS).  Results: COMT was shown to be associated 27 
with poor appetite/undereating (OR: 0.6, CI 95%: 0.43-0.83, p = 0.002).  Independent of 28 
obesity associations, the weighted GRS was associated to overeating in 13-15 year old 29 
females (OR: 2.07, CI 95%: 1.14-3.76, p = 0.017). Additionally, a significant association was 30 
observed between the GRS and loss of control over eating in the total sample (OR: 1.62, CI 31 
95%: 1.01-2.61, p = 0.046). Conclusions: The COMT variant (rs4680) was associated with 32 
poor appetite/undereating. Our study further confirms prior findings that obesity risk also 33 
confers risk for loss of control over eating; and overeating amongst girls. 34 
 35 
Keywords: Disordered eating, EAT-12, obesity polygenic risk score, COMT, HUNT, 36 
adolescents. 37 
 38 
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Abbreviations 44 
AN: Anorexia nervosa, BDNF: Brain derived neurotropic factor, BN: Bulimia nervosa, BED: 45 
Binge eating disorder, COMT: Catechol-O-methyl transferase gene, DE: Disordered eating, 46 
DRD2: Dopamine receptor D2 gene, ED: Eating disorder, FTO: Fat mass and obesity 47 
associated gene, GHRL: Ghrelin, GNPDA2: Glucosamine-6-phosphate deaminase 2,  GRB14: 48 
Growth factor Receptor-Bound protein 14 gene, GRS: Genetic risk score, 5-HT2A: Serotonin 49 
2A receptor,  INSIG2: Insulin induced gene 2,  KCTD15: Potassium channel tetramerization 50 
domain containing 15 gene, MC4R: Melanocortin 4 receptor gene, MSRA: Methionine 51 
sulfoxide reductase A,  MTCH2: Mitochondrial carrier 2 gene, NEGR1: Neuronal growth 52 
regulator 1, OFSED: Other specified feeding and eating disorders, OPRD1: Opioid Receptor 53 
delta 1 gene, SEC16B: Protein transport protein Sec16B,  SNP: Single nucleotide 54 
polymorphism, TFAP2B: Transcription factor AP-2 beta, TMEM18: Transmembrane protein 55 
18.     56 
 57 
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Introduction  65 
Eating disorders pose a significant health risk due to physical and  psychological 66 
comorbidities (Swanson, Crow, Le Grange, Swendsen, & Merikangas, 2011) including 67 
suicide rates as high as six times that of the healthy population (Arcelus, Mitchell, Wales, & 68 
Nielsen, 2011). Prevalence rates of full-threshold eating disorders (EDs), Anorexia Nervosa 69 
(AN), Bulimia Nervosa (BN) and Binge Eating Disorder (BED), are relatively low ranging 70 
with lifetime prevalence estimates between 0.5-1.0 % for AN and 0.5-3.0 % for BN (Swanson 71 
et al., 2011). The combined estimate of AN, BN and BED is ~5% (Stice, Marti, & Rohde, 72 
2013). Compared to full-threshold eating disorders, residual diagnoses are more common with 73 
Other Specified or Unspecified Feeding or Eating Disorders (OSFED) estimates of ~11.5%  74 
where approximately 13% of adolescents will experience at least one eating disorder by age 75 
20 (Stice et al., 2013). 76 
 77 
The term Disordered Eating (DE) is generally used for individuals who show signs and 78 
symptoms of ED without reaching the threshold for full blown eating disorders (Treasure, 79 
Claudino, & Zucker, 2010). The prevalence of disordered eating is high amongst adolescents 80 
(14-22%)(Micali, Solmi, et al., 2015; Treasure et al., 2010) with symptoms prospectively 81 
predicting the development of eating disorders (Jacobi, Hayward, de Zwaan, Kraemer, & 82 
Agras, 2004), and etiologic processes may be more closely linked to specific symptoms than 83 
to broad diagnoses (Cuthbert, 2005). 84 
 85 
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Twin and adoption studies have found moderate to high heritability of AN, BN, and BED (h2 86 
estimates: mean ~50%, range ~28–88%) and disordered eating symptoms (h2 estimates: mean 87 
~49%, range ~20–85%)(Culbert, Racine, & Klump, 2011) (Trace, Baker, Penas-Lledo, & Bulik, 88 
2013). However, the genetic architecture of ED and DE is far from being fully understood and still 89 
little is known concerning their neuropath physiology. There is, nevertheless, growing evidence 90 
that neurotransmitter networks that include dopaminergic and opioid systems are highly involved 91 
(Kessler, Hutson, Herman, & Potenza, 2016). Linkage studies have not been very successful but 92 
have generally suggested several chromosomal regions of interest (Trace et al., 2013). 93 
Furthermore, recent genetic studies with special emphasis on AN have failed to identify single 94 
genes with large effects (Boraska et al., 2012; Boraska et al., 2014; Pinheiro et al., 2010; Pinheiro, 95 
Root, & Bulik, 2009; Root et al., 2011) suggesting the inheritance complexity.  96 
 97 
Obesity and eating disorders share a number of risk factors that apply to a broad range of 98 
eating- and weight-related problems (Peckmezian & Hay, 2017). Studies indicate that 99 
common neurobiological mechanisms of eating disorders and obesity exist which involve 100 
regulation of food intake and emotion (Gorwood et al., 2016). Related to this, distortion of the 101 
balance between hunger and satiety linked to the rewarding aspect of food are thought to be 102 
linked to genetic predisposition. Interestingly, obesity susceptibility genes such as FTO, 103 
MC4R, BDNF, (Locke et al., 2015; Speliotes et al., 2010) and OPRD1 (Kvaloy, Kulle, 104 
Romundstad, & Holmen, 2013) have also been associated to disordered eating associated 105 
mechanisms (Micali, Field, Treasure, & Evans, 2015; Scherag, Hebebrand, & Hinney, 2010). 106 
Through  dopaminergic  and  opioidergic  influences on reward-related  processes, BED  107 
individuals  may  be  prone  to  elevated  food-related  hedonic  responses  (C. A. Davis et al., 108 
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2009). The rs6277  polymorphism  of  the  DRD2  gene  is  more  common in  obese  BED  109 
individuals  than  in  obese  non-BED  individuals (C. Davis et al., 2012; C. A. Davis et al., 110 
2009). In addition DRD2 has been associated to weight gain from normal weight to 111 
overweight/obesity longitudinally (Kvaloy, Holmen, Hveem, & Holmen, 2015).  112 
    113 
The approach of polygenic risk scores has been successfully used to acquire evidence of genetic 114 
effects when no single marker shows effects (Dudbridge, 2013). Obesity genetic risk scores (GRS) 115 
based on the GWAS-identified SNP effects have yielded a quantitative measure of inherited 116 
predisposition that has also been helpful in understanding obesity related traits and diseases. 117 
Furthermore, genetic risk scores have been useful in revealing genetically based mechanisms 118 
involved in unhealthy eating and weight gain related to eating behaviors such as appetitive traits 119 
(Konttinen et al., 2015; Steinsbekk, Belsky, Guzey, Wardle, & Wichstrom, 2016) and satiety 120 
mechanisms (Llewellyn, Trzaskowski, van Jaarsveld, Plomin, & Wardle, 2014). 121 
 122 
Disordered eating is highly prevalent at adolescence and is prospectively predicting the 123 
development of eating disorders at a later stage in life. Therefore, improved understanding of 124 
its etiology which is known to involve both environmental and genetic factors common with 125 
obesity susceptibility, is important.  Our overall study aims were to investigate whether 126 
disordered eating traits such as uncontrolled appetite/overeating and poor 127 
appetite/undereating are associated with genes involved in obesity development, altered 128 
reward processing, mood and appetite regulation and that these traits might share a genetic 129 
vulnerability in common with obesity.   To study this we used 24 single nucleotide 130 
polymorphisms previously linked to either obesity, weight measures or eating disorders in an 131 
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adolescent sample of 1,757 individuals (13-19 year olds) participating in the Norwegian 132 
Young-HUNT1 survey (1995-97). Improved knowledge of the molecular etiology involved 133 
seems of particular importance as it enhances the understanding not only about the molecular 134 
mechanisms involved, but also of an individual’s susceptibility to future eating disorders. 135 
More accurately being able to assess the progression of the symptoms earlier will hopefully 136 
aid in preventing development to a full-threshold eating disorder.  137 
 138 
Material and methods 139 
Study population 140 
The study participants were derived from the HUNT study, a large population based study 141 
conducted in three phases in the Nord-Trøndelag County, Norway (Krokstad et al., 2012). The 142 
HUNT study has one adult arm with participants aged ≥ 20 years (HUNT1 (1984-86) , 143 
HUNT2 (1995-97) and HUNT3 (2006-08) (Krokstad et al., 2013) and one adolescent arm  144 
with participants aged 13 to 19 years (Young-HUNT1 (1995-97), Young-HUNT2 (2000-01) 145 
and Young-HUNT3 (2006-08)) (Holmen et al., 2013). In all three surveys of the Young-146 
HUNT study, participants completed a comprehensive questionnaire during one school hour. 147 
Specially trained nurses visited the schools and performed clinical examinations including 148 
anthropometric measures and collection of buccal smears (Young-HUNT3). 149 
 150 
Young-HUNT1 recruited a total of 8,983 participants (response rate 88%) who completed the 151 
self-report questionnaire. Of the 8,983 individuals, only 8,433 had both anthropometric and 152 
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self-report data available for analysis. No blood samples were collected at this stage but blood 153 
samples were later retrieved from 1,805 participants who, as young adults, took part in the 154 
HUNT3 study (2006-08). Successful genotyping data was obtained from 1,801 participants in 155 
our study. Characterization of this sub-sample is described elsewhere (Cuypers et al., 2012; 156 
Kvaloy et al., 2013). 157 
 158 
Ethical approvals 159 
All research participants signed a written informed consent. In Norway, legal age for 160 
providing consent is 16 years, therefore in the case of participants younger than 16, consents 161 
were additionally given by parents or legal guardians.  The Young-HUNT study was 162 
approved by the Regional Committee for Ethics in Medical Research, the Norwegian Data 163 
Inspectorate and Directorate of Health. All procedures followed were in accordance with the 164 
ethical standards of the responsible committee on human experimentation (institutional and 165 
national) and with the Helsinki Declaration of 1975, as revised in 2000.  166 
 167 
Eating Attitude Test and case group categorization 168 
The Eating Attitude Test (EAT) originally  consisted of 40 items (Garner & Garfinkel, 1979), 169 
but has subsequently been shortened to EAT-26 (Mann et al., 1983) and further to 12 items 170 
(EAT-12) (Lavik, Clausen, & Pedersen, 1991) consisting of three factors; 1) dieting, 2) 171 
bulimia and food preoccupation and 3) oral control. Since the EAT-12 was originally deemed 172 
too long to be used in the HUNT study, a shortened 7-item version (EAT-7) missing the 173 
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dieting item was instead used to determine disordered eating in Young-HUNT1 (Bjomelv, 174 
Mykletun, & Dahl, 2002). The dieting factor was, however, included separately elsewhere in 175 
the questionnaire. Bjørnelv et al. validated the 7-item version (EAT-7) towards the 12-item 176 
version (EAT-12)  (Bjomelv et al., 2002) and reported a two-factor solution robust for age and 177 
gender, EAT-A (poor appetite/undereating) and EAT-B (uncontrolled appetite/overeating), 178 
when they investigated the psychometric properties of the EAT-7 in comparison with EAT-179 
12. Cronbach’s alpha ranged from 0.48 to 0.69 for factor B items and from 0.41 to 0.51 for 180 
factor A items (Bjomelv et al., 2002). The internal consistency of EAT-A and EAT-B in a 181 
recent study was, 0.512 and 0.695, respectively (Eik-Nes et al., 2015). The EAT-A consists of 182 
the following items: 1) When I eat, I cut my food up into small pieces; 2) It takes me longer 183 
than it takes others to finish a meal; 3) Other people think I am too thin and 4) I feel that 184 
others pressure me to eat. The EAT-B consists of the following items: 1) When I first begin 185 
eating, it is difficult to stop (overeating); 2) I spend too much time thinking about food (food 186 
preoccupation); 3) I feel that food controls my life (loss of control eating). The four-point 187 
Likert scale with answers: “never”, “seldom”, “often” and “always” was converted to a three-188 
point scale with the response options: never/seldom, often and always coded as 0, 1 and 2, 189 
respectively. This gave a maximum score of 8 for EAT-A and 6 for EAT-B where the sum of 190 
the individual item scores were calculated separately for EAT-A and EAT-B. Cut-off points 191 
were as outlined by Bjørnelv et al, with scores ≥ 3 for EAT-A and ≥ 2 for EAT-B as 192 
indicative of DE (Bjomelv et al., 2002). Controls were those who scored less than the cut-offs 193 
for both EAT-A and EAT-B.  194 
 195 
Anthropometric measurements 196 
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Standardized measurements of height and weight were carried out by trained nurses during 197 
data collection. Participants wore light clothing and no shoes. Weight was measured to the 198 
nearest half kilo and height to the nearest cm. BMI (body mass index) was calculated as 199 
weight (kg)/height2 (m2). In interpreting BMI in adolescents considerations with regard to age 200 
and sex were taken. BMI z-scores (zBMI) were calculated based on mean BMI and SD for 201 
each Young-HUNT1 sex and year groups. BMI based weight group characterizations were 202 
calculated according to Cole (Cole, Bellizzi, Flegal, & Dietz, 2000; Cole, Flegal, Nicholls, & 203 
Jackson, 2007) and a summary and distribution within the EAT-A and EAT-B case groups 204 
can be found in Table 1. 205 
 206 
Genetic material and candidate gene selection 207 
The following genetic variants for nine of the robustly associated obesity-susceptibility loci at 208 
the time of the study design (early 2010) (Loos et al., 2008; Thorleifsson et al., 2009; Willer 209 
et al., 2009) was included in our study: rs9939609, rs8050136, rs1121980 (in FTO), 210 
rs12970134, rs17782313, rs17782313 (near MC4R), rs2815752 (near NEGR1), rs6548238 211 
(near TMEM18), rs10938397 (near GNPDA2), rs10838738 (in MTCH2), rs4074134, 212 
rs925946, rs6265 (near/in BDNF), rs987237 (in TFAP2B) and rs543874 (near SEC16B).  213 
Additionally, the following 15 genetic variants previously associated to weight measures or 214 
suggested to be implicated in eating disorders (Lindgren et al., 2009; Rask-Andersen, 215 
Olszewski, Levine, & Schioth, 2010; Zhao et al., 2009) were added:  rs11084753 (near 216 
KCTD15), rs7566605 (near INSIG2), rs545854 (near MSRA), rs3734967 (near 5-HT2A), 217 
rs4680 (in COMT), rs569356 (near OPRD1), rs35683 (in GHRL), rs6277 (in DRD2), 218 
rs10195252 (near GRB14). SNPs with lower call rates than 95% were excluded from our 219 
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study as well as individuals with > 10% genotypes missing. All included SNPs were in 220 
Hardy-Weinberg equilibrium. Genotype frequencies were in agreement with previous 221 
findings in European populations (NCBI, The National Center for Biotechnology 222 
Information). Genotyping procedures and SNP characteristics are described elsewhere 223 
(Kvaloy et al., 2013) and summarized in Table 2. 224 
 225 
Statistical analyses 226 
Descriptive characterizations and file preparations were done using IBM SPSS statistics 227 
(version 21). PLINK was used for the genetic analyses (Purcell et al., 2007). In order to study 228 
possible associations between single SNPs and outcome phenotypes, logistic regression 229 
models were employed testing SNPs in additive models. Analyses were done on the whole 230 
study sample and sex stratified samples. BMI was conceptualized as a confounder and z-231 
scores (zBMI) adjusted for in the single SNP conditional models.  232 
 233 
The obesity Genetic Risk Scores (GRSs) was calculated by summing up the number of BMI-234 
increasing risk alleles both using weighted and unweighted GRS exposures. The unweighted 235 
GRS (uGRS) was calculated by summing the number of risk alleles across 10 variants and the 236 
weighted GRS (wGRS) was calculated by multiplying the number of risk alleles at each locus 237 
(0, 1, 2) with the corresponding effect sizes, in kg/m2 per allele (beta), as reported by 238 
Speliotes et al. based on adult BMI associations (Speliotes et al., 2010). In the wGRS the loci 239 
in or near FTO (rs1121980), TMEM18 (rs6548238), MC4R (rs571312), NEGR1 (rs2815752), 240 
GNPDA2 (rs10938397), BDNF (rs6265), MTCH2 (rs10838738), TFAP2B (rs987237) and 241 
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SEC16B (rs543874) were identical or in high linkage disequilibrium (r2>0.8, except for 242 
rs6265 with r2= 0.7) to the ones published (Speliotes et al., 2010). In the uGRS, KCTD15 243 
(rs11084753) which was not in high LD with the proxy analyzed (r2 = 0.5) by Speliotes et al. 244 
(Speliotes et al., 2010), was included. The risk allele effects are outlined in Table 2. GRS 245 
analyses were performed using logistic regression models (IBM SPSS statistics, version 22). 246 
An additional weighted GRS based on genetic data available through a very recent release 247 
from the HUNT study was included in the study comprising all 32 obesity susceptibility 248 
variants identified by Speliotes et al., (Speliotes et al., 2010).  249 
 250 
In general, nominal significance was considered at p < 0.05. Additionally, a permutation-251 
based test using a basic Max (T) with 1000 permutation specified was used in order to adjust 252 
for multiple testing of the SNPs in the single SNP analyses. The Max (T) permutation method 253 
employed in PLINK for multiple testing equals stringency of Bonferroni correction when 254 
single SNPs are tested. Odds Ratios (ORs) are presented with 95% confidence intervals (CI). 255 
 256 
Results 257 
Study subjects 258 
Due to missing genotypes, weight measurements or data on EAT question items, only 1,757 259 
(F: 979, M: 778) of the original 1,801 Young-HUNT1 research participants were available for 260 
analyses. Among these, 88 cases with poor appetite/undereating (F: 53, M: 35)(EAT-A) and 261 
152 cases with uncontrolled appetite/overeating (F: 111, M: 41)(EAT-B) were compared with 262 
1,530 controls (see Table 1). Thirteen individuals positive for both EAT-A and EAT-B, were 263 
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included in the separate analyses. The mean age was slightly higher among the cases (16.1 – 264 
16.3 years) compared to the controls (15.9 years) and the mean BMI was higher in the 265 
uncontrolled appetite/overeating cases (22.18± 3.6) compared to the poor appetite/undereating 266 
cases (20.07±2.7). There was a higher percentage of overweight (15.8%) and obese (3.9%) 267 
cases with uncontrolled appetite/overeating compared to the cases with poor 268 
appetite/undereating (overweight: 4.6%, obese: 1.1%). Furthermore, a higher percentage of 269 
underweight amongst cases with poor appetite/undereating (9.2%) compared to cases with 270 
uncontrolled appetite/overeating (4.6%) was observed (Table 1).   271 
 272 
Associations between individual genetic variants and poor appetite/undereating (EAT-273 
A) 274 
In the minimally adjusted and BMI-conditionally adjusted model the G-allele of rs4680 275 
(COMT) was protective towards suffering from poor appetite/undereating (EAT-A) in the 276 
total sample even after multiple testing (OR: 0.60, CI 95% 0.43-0.83, p = 0.002 and adjusted 277 
p= 0.035) (Table 3). The association was nearly significant after multiple testing in females 278 
(OR: 0.54, CI 95% 0.35-0.82, p = 0.004 and adjusted p= 0.074), but not in males.  279 
 280 
The following SNPs were significantly associated with poor appetite/undereating  at nominal 281 
levels: rs11084753 (KCTD15) in the minimally adjusted and BMI-adjusted model with an 282 
OR: 1.44 (CI: 95% 1.04-1.99, p = 0.027 for the A-allele in the total sample with an even 283 
stronger effect in males (OR: 2.09 (CI: 95% 1.24-3.51, p = 0.006), and rs35683 (GHRL) in the 284 
total sample with an OR: 1.35, CI: 95% 1.00-1.83, p = 0.049 in the conditional model. The G-285 
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allele of rs987237 (TFAP2B) was nominally significantly associated in females in the 286 
conditionally adjusted model (OR: 1.72, CI: 95% 1.07-2.76, p = 0.025).  287 
 288 
Associations between individual genetic variants and uncontrolled appetite/overeating 289 
(EAT-B)  290 
Only nominally significant associations were observed with the uncontrolled 291 
appetite/overeating (EAT-B) trait as outcome. The G-allele of rs987237 (TFAP2B) was 292 
positively associated in both minimally adjusted and adjusted models (OR: 1.37 (CI: 95% 293 
1.03-1.84, p = 0.034) (Table 4). This association was only present in females in the stratified 294 
analyses (OR: 1.44 (CI: 95% 1.02-2.05, p = 0.040). The C-allele of rs35683 (GHRL) was also 295 
positively associated (OR: 1.34 (CI: 95% 1.06-1.70, p = 0.015), while the rs10938397 296 
(GNPDA2) G-allele had a protective effect (OR: 0.76 (CI: 95% 0.59-0.98, p = 0.035). The T–297 
allele of rs1121980 (FTO) conferred risk of uncontrolled appetite/overeating (OR: 1.34 (CI: 298 
95% 1.00-1.78, p = 0.047) in the female only adjusted model.  299 
 300 
Effects of the obesity polygenic risk scores (GRSs) on disordered eating  301 
Nine obesity risk loci were included in the weighted and 10 in the unweighted GRSs. 302 
Association effects of the unweighted GRS (uGRS) were similar although weaker compared 303 
to the weighted GRS (wGRS)(data for uGRS not show). Due to the significant sex interaction 304 
identified between the wGRS and uncontrolled appetite/overeating (EAT-B), logistic 305 
regression analyses were sex stratified. Overeating (EAT-B Stop) was additionally stratified 306 
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by age groups (13-15 and 16-19 years) due to significant wGRS*age interaction identified. 307 
There were no significant associations detected between the wGRS and the poor 308 
appetite/undereating sub-scale (EAT-A). Supplementary information is shown in Table S1 309 
(Online resource).  Independent of obesity associations, wGRS was significantly associated to 310 
loss of control eating (EAT-B Cont) in the total sample (OR: 1.62, CI 95%: 1.01-2.61, p = 311 
0.046) and a significant association was additionally observed between the wGRS and 312 
overeating (EAT-B Stop) in 13-15 year old females (OR: 2.07, CI 95%: 1.14-3.76, p = 0.017).  313 
   314 
Replication of the associations between the wGRS and various EAT-B sub-scale outcomes 315 
were performed using an extended wGRS (wGRS-32) consisting of 32 obesity increasing 316 
variants (Supplementary table S2 – Online resource). The directions of effects were in 317 
agreement with results obtained with the 9-SNP wGRSs although mostly weaker except for an 318 
additional significant association between loss of control eating, EAT-B Cont, and wGRS-32 319 
in females (OR: 1.69, CI 95%: 1.06-2.70, p = 0.027).  EAT-B Cont was also significantly 320 
associated in the total sample (OR: 1.47, CI 95%: 1.02-2.12, p = 0.041) although not after 321 
adjustment with BMI. The female-specific association was nearly significant independent of 322 
obesity (p = 0.057). The significant association identified between the 9-SNP wGRS and 323 
overeating (EAT-B Stop) in 13-15 year old females was nearly significant in the wGRS-32 (p 324 
= 0.078).     325 
  326 
Discussion 327 
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In this study we investigated the effect of 24 genetic variants previously associated with 328 
obesity and eating disorders against poor appetite/undereating and uncontrolled 329 
appetite/overeating in adolescents (13-19 years).  We were able to show that the catechol-O-330 
methyltransferase (COMT) gene was associated to poor appetite/undereating (AN like 331 
behaviors) while obesity susceptibility variants through  genetic risk scores, which 332 
quantitatively strengthens the effects compared to single variant effects, were associated to 333 
uncontrolled appetite/overeating (BN and BED like behaviors). 334 
 335 
The most interesting single variant finding was a protective effect displayed by the G-allele of 336 
the COMT Val158Met variant rs4680 on poor appetite/undereating independent of BMI both 337 
in the total and female only sample. The Val158Met COMT is a functional polymorphism 338 
with enzyme altering activity. It has been extensively studied in relation to drug dependence, 339 
bipolar disorder and schizophrenia  (Ioannidis, Serfontein, & Muller, 2014) and seems to 340 
influence  the reward mechanisms linked to several aspects of aberrant eating  (Donofry et al., 341 
2014; Yilmaz, Kaplan, Zai, Levitan, & Kennedy, 2011). In a recent large community sample, 342 
the COMT Met allele was shown to confer risk both with regards to bulimic symptoms and 343 
severe body dissatisfaction (Donofry et al., 2014).   344 
 345 
Although not reaching robust significance levels for many of the single variants, the pattern of 346 
genetic associations differed between the poor appetite/undereating and uncontrolled 347 
appetite/overeating phenotypes. KCTD15 (Potassium channel tetramerization domain 348 
containing 15) and GHRL (Ghrelin) were both associated with poor appetite/undereating in 349 
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males and in the total sample for KCTD15. Previously, KCTD15 has been associated 350 
primarily with obesity (Speliotes et al., 2010) as well as being a gene of interest for eating 351 
disorders (Rask-Andersen et al., 2010). Ghrelin, an orexigenic peptide secreted mainly from 352 
the stomach, increases appetite and food intake and is found to be low in blood samples of 353 
AN patients. However, association studies linking Ghrelin polymorphisms and ED have been 354 
somewhat contradictory, with the majority reporting no significant associations with AN 355 
(Trace et al., 2013). Deranged Ghrelin response to hedonic eating present in underweight 356 
patients with AN has been suggested to be related to reduced motivation toward food intake 357 
(Maria Monteleone et al., 2016). Our results give further support to the association between 358 
Ghrelin and disordered eating and more specifically anorexic behaviors.  359 
 360 
Many confirmed genetic loci for obesity are expressed in regions of the brain that regulate 361 
energy intake and reward-seeking behavior. In the single marker testing performed here, 362 
TFAP2B (Transcription factor AP-2 beta), GNPDA2 (Glucosamine-6-phosphate deaminase 2) 363 
and FTO (Fat mass and obesity associated gene) showed evidence of association with the 364 
uncontrolled/overeating phenotype. In a recent study by Cornelis and colleagues (Cornelis et 365 
al., 2014), the TFAP2B was shown to be associated with cognitive restraint which is 366 
interesting with regards to DE. Furthermore, GNPDA2 has previously been associated to 367 
obesity (Heid, 2010; Speliotes, 2010), but not directly to eating behavior or eating disorders. 368 
FTO has been shown to be of particular importance in regulating body weight as well as being 369 
implicated in behavioral and cognitive aspects of overeating (Hinney & Volckmar, 2013). 370 
Previously, FTO has been identified as a gene of interest with regards to AN (Boraska et al., 371 
2014), drive for thinness, bulimia and weight fluctuations (Boraska et al., 2012). In our 372 
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sample  FTO was associated  with DE in females at a nominal significance level after 373 
adjustments for BMI suggesting a weight independent effect and underlining the notion of 374 
FTO’s role in disordered eating (Micali, Field, et al., 2015). Whether this observed effect is 375 
due to FTO affecting appetite and satiety is also interesting to explore. The FTO gene has 376 
previously been shown to be associated with loss of control over eating (Muller et al., 2012; 377 
Tanofsky-Kraff et al., 2009) and Micali and colleagues have very recently found strong 378 
associations between binge eating and FTO (Micali, Field, et al., 2015) which further supports 379 
the evidence of FTO’s effect on appetite and food intake. Satiety and hunger have also been 380 
linked to eating behavior through FTO and MC4R (Melanocortin 4 receptor gene) (Stutzmann 381 
et al., 2009; Wardle, Carnell, Haworth, & Plomin, 2008).  382 
 383 
In our study the use of genetic risk scores enabled us to identify effects asserted by the 384 
combined obesity susceptibility SNP-effect on the uncontrolled appetite/overeating trait 385 
specified by EAT-B. Furthermore, we more specifically identified single EAT-B items to be 386 
of particular interest.  The obesity GRS was positively associated with loss of control eating 387 
in the total sample, and with overeating in the young adolescent females.  Previous findings of 388 
Llewellyn and colleagues (Llewellyn et al., 2014) showed that the obesity GRS negatively 389 
influenced satiety responsiveness in a sample of 10 year old children and suggested that 390 
obesity risk variants influence adiposity via appetite regulatory mechanisms. This is not 391 
unexpected as many of the so far identified obesity susceptibility SNPs are within or near 392 
genes known to regulate appetite (Locke et al., 2015).  Directions of effects were comparable 393 
using the two weighted GRSs although weaker associations were in general identified when 394 
the extended GRS including 32 obesity risk-variants was used. The discrepancy between the 395 
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GRS-analyses could be due to several reasons: 1) that the extended GRS included imputed 396 
SNPs in addition to directly analysed ones which makes it less accurate, 2) that the addition of 397 
more SNPs makes the distribution within the scores slightly different and 3) that the analyses 398 
with the extended GRS included fewer cases compared to the GRS with nine SNPs.  399 
 400 
Knowledge of factors influencing disordered eating among males is scarce. The prevalence of 401 
eating disorders in males are additionally assumed to be much lower than in females although 402 
binge eating disorder (BED), shows a life-time prevalence closer to 1:1 for males and females 403 
(1.6% and 2.0%, respectively) (Hudson, Hiripi, Pope, & Kessler, 2007).  Both sexes were 404 
represented in our study and quite high proportions of DE comparing males to females were 405 
identified; 39.8% (n=35 of a total of n=88) reported poor appetite/undereating (EAT-A) and 406 
27.0% (n=41 of a total of n=152) uncontrolled appetite/overeating (EAT-B).  407 
 408 
A strength of this study was that anthropometric and clinical measurements were carried out 409 
by trained personnel avoiding the pitfall of under- or misreporting weight related measures 410 
(Park et al., 2011). Additionally, the HUNT population comprises a very ethnically 411 
homogenous sample. The main limitation in our study is the rather low number of cases as 412 
expected for rare phenotypes or diseases and thus no statistical significance might be due to 413 
lack of power. Also adding more obesity SNPs to the polygenic risk score would probably 414 
more precisely capture the genetic predisposition. Furthermore, the effect sizes included in the 415 
weighted GRS were based on adult effects which may not fully correlate with the adolescent 416 
effects. However, there is evidence for higher heritability of BMI in children compared to 417 
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adults (Elks et al., 2012) which would imply larger effect estimates if using an obesity genetic 418 
risk score based on adolescent effects. 419 
 420 
The genetic data was only retrieved from the individuals who participated both at adolescence 421 
in Young-HUNT1 (1995-97) and as young adults in HUNT3 (2006-08). At HUNT3 the 422 
lowest participation rate was unfortunately within our target age group (20-39 years). In a 423 
non-participant study performed after the HUNT3 survey (Langhammer, Krokstad, 424 
Romundstad, Heggland, & Holmen, 2012), the prevalence of cardiovascular diseases, diabetes 425 
mellitus and psychiatric disorders were higher in general compared to the participants 426 
including all age groups. In the age group of 20-39 years the majority of non-participants 427 
report not to have met due to “not receiving an invitation” (14.1%) or “not having the time to 428 
meet” (62.6%).We therefore believe that our sample was representative of the Young-HUNT1 429 
participants in general.  430 
 431 
Several of the sub-analyses may be underpowered due to lack of cases to include. The sample 432 
size required for detecting associations is known to be affected by disease prevalence, disease 433 
allele frequency, linkage disequilibrium (LD), inheritance models and effect size of the 434 
genetic variant. In our study, the disease prevalence is low and the effect sizes of each genetic 435 
variant are probably low. In the case of the COMT variant rs4680 which was found to be 436 
significantly associated to poor appetite/undereating, we know that the disease/risk allele 437 
frequency is high (approximately 0.5). The rs4680 is additionally a functional variant 438 
localised within the COMT gene, i.e. LD=1. Together these last-mentioned factors will affect 439 
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the statistical power positively.  According to calculations done by Hong and Park (Hong & 440 
Park, 2012) computing the effective sample size and statistical power using a web browser 441 
program, Genetic Power Calculator developed by Purcell et al. (Purcell, Cherny, & Sham, 442 
2003)(http://pngu.mgh.harvard.edu/~purcell/gpc/), the smallest sample size in a dominant 443 
model to achieve 80% power using a single SNP in a case-control study under the 444 
assumptions of 5% disease prevalence, 5% MAF, LD=1 and 1:1 case-control ratio is 90 cases. 445 
 446 
Although we found a strong association between rs4680 COMT and the poor 447 
appetite/undereating, the strength of evidence for many of the other associations were not 448 
always backed by multiple testing. To our knowledge, our study is one of very few to study 449 
gene associations of DE in a population based sample of European ancestry and our findings 450 
show that even in a population based sample, there are indications of associations between the 451 
dopaminergic and melanocortin pathways and DE. Our findings need further replication in 452 
larger studies.  453 
 454 
In conclusion, differential patterns of associations were found between sets of genetic markers 455 
for poor appetite/undereating and uncontrolled appetite/overeating. The Val allele of the 456 
COMTVal158Met variant rs4680 was protective for the poor appetite/undereating trait. The 457 
obesity genetic risk score was independent of obesity association, risk-conferring for loss of 458 
control eating and overeating, confirming the correlation between obesity susceptibility and 459 
disordered eating.  460 
 461 
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Table 1. Characteristics of the study sample. 
 
  EAT-A EAT-B Controls  
  Cases (n=88) Cases (n=152) (n=1530)  
Gender, females, n (%) 53 (60.2%) 111 (73.0%) 823 (53.8%) 
Age,mean (SD) 16.0 (1.8) 16.3 (1.8) 15.9 (1.8) 
BMI1, mean (SD) 20.07 (2.7) 22.18 (3.6) 21.27 (3.2) 
wGRS2, mean (SD) 1.79 (0.04) 1.81 (0.03) 1.79 (0.01) 
uGRS3, mean (SD) 9.48 (0.22) 9.66 (0.16) 9.65 (0.49) 
Underweight, n (%)4 8 (9.2%) 7 (4.6%) 95 (6.2%) 
Normal weight, n (%)4 71 (81.6%) 108 (71.1%) 1148 (75.0%) 
Overweight, n (%)4 4 (4.6%) 24 (15.8%) 192(12.5%) 
Obese, n (%)4 1 (1.1%) 6 (3.9%) 31 (2.0%) 
 
1BMI; Body mass index, 2 wGRS; weighted Genetic Risk Score, 3 uGRS; unweighted Genetic Risk Score 4 Weight categories defined according 
to IOTF (Cole, Bellizzi, Flegal, & Dietz, 2000; Cole, Flegal, Nicholls, & Jackson, 2007). Less cases in the weight groups due to missing weight 
data. 
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Table 2. SNP characteristics. 
 
Nearby 
gene 
CHR SNP BP Call rate 
(%) 
Minor 
allele 
Other 
allele 
MAF Proxy 
SNP1 
Per risk allele 
change in 
BMI, beta2 
  
OPRD1 1 rs569356 29009273 98.9 G A 0.129      
NEGR1 1 rs2815752 72585028 99.7 G A 0.406  0.13    
SEC16B 1 rs543874 176156103 99.6 C T 0.237  0.22    
TMEM18  2 rs6548238 624905 99.4 T C 0.166 rs2867125 0.31    
INSIG2 2 rs7566605 118552495 99.0 C T 0.357      
GRB14 2 rs10195252 165221337 99.4 C T 0.417      
GHRL 3 rs35683 10303250 99.8 A C 0.443      
GNPDA2  4 rs10938397 44877284 99.4 G A 0.389  0.18    
TFAP2B 6 rs987237 50911010 98.4 G A 0.178  0.13    
5-HT2A 7 rs3734967 154493441 99.6 G A 0.292      
MSRA 8 rs545854 9897490 99.8 G C 0.179      
BDNF 11 rs4074134 27603861 99.7 T C 0.184      
BDNF 11 rs925946 27623778 99.4 A C 0.348      
BDNF 11 rs6265 27636492 99.8 A G 0.182 rs10767664 0.19    
MTCH2 11 rs10838738 47619625 99.6 C T 0.364 rs3817334 0.06    
DRD2  11 rs6277 112788669 99.7 C T 0.466      
FTO 16 rs1121980 52366748 99.7 T C 0.446 rs1558902 0.39    
FTO 16 rs8050136 52373776 99.8 A C 0.411      
FTO 16 rs9939609 52378028 99.7 A T 0.412      
MC4R 18 rs571312 55990749 99.1 A C 0.268  0.23    
MC4R 18 rs17782313 56002077 98.4 C T 0.268      
MC4R 18 rs12970134 56035730 99.7 A G 0.300      
KCTD15 19 rs11084753 39013977 99.2 A G 0.307      
COMT 22 rs4680 18331271 99.7 G A 0.449       
Minor allele is set as reference in the analyses. Effect allele underlined in SNPs used in the weighted GRS. 1 Effect sizes by Speliotes et al., 2010.  
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2 Linkage disequilibrium between genotyped SNP and SNP used as reference in the weighted GRS analysis (Speliotes et al., 2010). CHR = 
Chromosome, SNP = Single nucleotide polymorphism, BP = Base pair, MAF=Minor allele frequency.  
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Table 3. Association between EAT-A (poor appetite/undereating sub-scale) and genetic variants in the total study sample and sex stratified. 
           
  Minimally adjusted1  
(n=88 cases) 
  Conditional on zBMI2 
(n=88 cases) 
 Males conditional on zBMI  
(n=35 cases) 
Females conditional on zBMI 
                  (n=53 cases) 
 
SNP Putative gene OR (95% CI) P P3 OR  (95% CI) P P3 OR  (95% CI) P P3 OR  (95% CI) P P3 
rs569356 OPRD1 1.06 (0.69-1.64) 0.791 1 1.06 (0.69-1.64 0.791 1 0.73 (0.33-1.62) 0.446 1 1.29 (0.76-2.18) 0.345 1 
rs2815752 NEGR1 1.01 (0.74-0.38) 0.964 1 1.01 (0.74-1.38) 0.964 1 0.89 (0.54-1.44) 0.629 1 1.11 (0.74-1.67) 0.626 1 
rs543874 SEC16B 1.10 (0.8-1.55) 0.601 1 1.10 (0.78-1.55) 0.605 1 0.66 (0.35-1.22) 0.185 0.980 1.49 (0.97-2.29) 0.072 0.796 
rs6548238 TMEM18 0.90 (0.59-1.38) 0.623 1 0.90 (0.59-1.38) 0.626 1 0.64 (0.30-1.38) 0.258 1 1.07 (0.64-1.79) 0.795 1 
rs7566605 INSIG2 1.18 (0.87-1.60) 0.297 0.998 1.18 (0.87-1.60) 0.296 0.997 1.25 (0.78-2.01) 0.348 1 1.13 (0.76-1.69) 0.552 1 
rs10195252 GRB14 0.82 (0.60-1.13) 0.225 0.993 0.82 (0.60-1.13) 0.222 0.993 0.87 (0.52-1.45) 0.595 1 0.79 (0.53-1.18) 0.247 0.995 
rs35683 GHRL 1.35 (1.0-1.83) 0.050 0.640 1.35 (1.00-1.83) 0.049 0.616 1.30 (0.81-2.08) 0.273 1 1.39 (0.94-2.05) 0.100 0.892 
rs10938397 GNPDA2 0.92 (0.67-1.25) 0.586 1 0.92 (0.67-1.25) 0.588 1 0.93 (0.56-1.54) 0.786 1 0.91 (0.61-1.36) 0.660 1 
rs987237 TFAP2B 1.33 (0.91-1.94) 0.136 0.940 1.33 (0.91-1.94) 0.136 0.952 0.91 (0.48-1.72) 0.769 1 1.72 (1.07-2.76) 0.025 0.393 
rs3734967 5-HT2A 1.05 (0.75-1.47) 0.767 1 1.05 (0.75-1.48) 0.758 1 1.01 (0.59-1.74) 0.963 1 1.09 (0.71-1.68) 0.697 1 
rs545854 MSRA 1.20 (0.81-1.76) 0.352 1 1.20 (0.82-1.76) 0.352 0.999 1.63 (0.92-2.88) 0.095 0.857 0.96 (0.57-1.62) 0.870 1 
rs4074134 BDNF 1.34 (0.93-1.92) 0.115 0.908 1.34 (0.93-1.92) 0.117 0.918 1.40 (0.81-2.45) 0.231 0.999 1.29 (0.80-2.08) 0.302 0.999 
rs925946 BDNF 1.02 (0.74-1.40) 0.929 1 1.02 (0.74-1.40) 0.920 1 0.86 (0.51-1.44) 0.555 1 1.14 (0.76-1.71) 0.535 1 
rs6265 BDNF 1.23 (0.84-1.78) 0.284 0.997 1.23 0.84-1.78) 0.287 0.997 1.22 (0.68-2.20) 0.508 1 1.23 (0.75-2.00) 0.409 1 
rs10838738 MTCH2 1.00 (0.73-1.36) 0.988 1 1.00 (0.73-1.36) 0.989 1 0.88 (0.53-1.44) 0.609 1 1.09 (0.73-1.63) 0.675 1 
rs6277 DRD2 0.99 (0.73-1.34) 0.930 1 0.99 (0.73-1.34) 0.931 1 0.69 (0.42-1.13) 0.140 0.953 1.24 (0.84-1.83) 0.280 0.999 
rs1121980 FTO 0.99 (0.73-1.35) 0.960 1 0.99 (0.73-1.35) 0.961 1 0.84 (0.51-1.38) 0.492 1 1.10 (0.74-1.64) 0.629 1 
rs8050136 FTO 1.09 (0.80-1.50) 0.572 1 1.09 (0.80-1.50) 0.571 1 0.98 (0.60-1.62) 0.946 1 1.17 (0.79-1.75) 0.438 1 
rs9939609 FTO 1.09 (0.80-1.49) 0.588 1 1.09 (0.80-1.49) 0.587 1 0.97 (0.59-1.61) 0.917 1 1.17 (0.79-1.75) 0.438 1 
rs571312 MC4R 0.87 (0.61-1.24) 0.436 1 0.87 (0.60-1.24) 0.433 1 0.96 (0.56-1.65) 0.894 1 0.79 (0.49-1.29) 0.346 1 
rs17782313 MC4R 0.87 (0.61-1.25) 0.446 1 0.87 (0.61-1.24) 0.444 1 0.97 (0.57-1.66) 0.915 1 0.79 (0.49-1.28) 0.345 1 
rs12970134 MC4R 0.84 (0.59-1.19) 0.319 0.999 0.84 (0.59-1.19) 0.318 0.999 0.76 (0.44-1.31) 0.328 1 0.89 (0.57-1.40) 0.627 1 
rs11084753 KCTD15 1.44 (1.04-1.99) 0.027 0.434 1.44 (1.04-1.99) 0.027 0.407 2.09 (1.24-3.51) 0.006 0.093 1.14 (0.75-1.74) 0.532 1 
rs4680 COMT 0.60 (0.43-0.84) 0.002 0.046 0.60 (0.43-0.83) 0.002 0.035 0.71 (0.42-1.20) 0.204 0.990 0.54 (0.35-0.82) 0.004 0.074 
1Minimally adjusted models are adjusted for sex. 2Conditional models were adjusted for age adjusted z-scores of BMI. Significant results 
(P<0.05) are marked with bold. P3 - Empirical P-value corrected for multiple testing by 1000 permutations. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 4. Association between EAT-B (uncontrolled appetite/overeating sub-scale) and genetic variants in the total study sample and sex 
stratified. 
 
  
Minimally adjusted1 
(n=152 cases)   
Conditional on zBMI2 
(n=152 cases)  
Males conditional on zBMI 
(n=41 cases) 
Females conditional on zBMI 
(n=111 cases)   
SNP Putative gene OR  (95% CI) P P3 OR  (95% CI) P P3 OR  (95% CI) P P3 OR  (95% CI) P P3 
rs569356 OPRD1 0.80 (0.55-1.61) 0.237 0.994 0.80 (0.55-1.16) 0.238 0.995 0.79 (0.39-1.60) 0.512 1 0.80 (0.51-1.25) 0.324 1 
rs2815752 NEGR1 0.91 (0.71-1.17) 0.471 1 0.91 (0.71-1.17) 0.470 1 0.82 (0.52-1.29) 0.382 1 0.96 (0.71-1.29) 0.776 1 
rs543874 SEC16B 0.96 (0.73-1.27) 0.792 1 0.96 (0.73-1.27) 0.797 1 0.77 (0.44-1.32) 0.336 1 1.06 (0.76-1.47) 0.743 1 
rs6548238 TMEM18 0.89 (0.64-1.24) 0.483 1 0.89 (0.64-1.23) 0.479 1 1.24 (0.70-2.21) 0.463 1 0.77 (0.51-1.15) 0.199 0.994 
rs7566605 INSIG2 0.91 (0.71-1.16) 0.442 1 0.91 (0.71-1.16) 0.442 1 0.80 (0.50-1.28) 0.359 1 0.96 (0.71-1.28) 0.769 1 
rs10195252 GRB14 1.00 (0.78-1.27) 0.979 1 1.00 (0.78-1.27) 0.975 1 1.06 (0.67-1.68) 0.809 1 0.97 (0.73-1.29) 0.838 1 
rs35683 GHRL 1.34 (1.06-1.70) 0.014 0.257 1.34 (1.06-1.70) 0.015 0.274 1.43 (0.92-2.22) 0.109 0.916 1.31 (0.99-1.73) 0.059 0.719 
rs10938397 GNPDA2 0.76 (0.59-0.98) 0.036 0.531 0.76 (0.59-0.98) 0.035 0.517 0.73 (0.45-1.19) 0.204 0.994 0.78 (0.58-1.05) 0.097 0.881 
rs987237 TFAP2B 1.37 (1.03-1.84) 0.033 0.504 1.37 (1.03-1.84) 0.034 0.503 1.23 (0.72-2.11) 0.443 1 1.44 (1.02-2.05) 0.040 0.562 
rs3734967 5-HT2A 0.97 (0.74-1.26) 0.811 1 0.97 (0.74-1.26) 0.794 1 0.97 (0.59-1.62) 0.922 1 0.97 (0.71-1.32) 0.822 1 
rs545854 MSRA 0.91 (0.66-1.26) 0.587 1 0.92 (0.66-1.26) 0.588 1 0.94 (0.51-1.74) 0.844 1 0.91 (0.62-1.32) 0.607 1 
rs4074134 BDNF 0.72 (0.52-1.01) 0.060 0.734 0.73 (0.52-1.02) 0.061 0.697 0.62 (0.32-1.21) 0.163 0.978 0.77 (0.52-1.13) 0.181 0.989 
rs925946 BDNF 1.05 (0.82-1.35) 0.692 1 1.05 (0.82-1.34) 0.710 1 0.77 (0.47-1.26) 0.291 0.997 1.18 (0.88-1.57) 0.268 1 
rs6265 BDNF 0.73 (0.52-1.02) 0.065 0.758 0.73 (0.52-1.02) 0.067 0.733 0.55 (0.27-1.12) 0.100 0.874 0.80 (0.54-1.18) 0.258 1 
rs10838738 MTCH2 0.89 (0.70-1.14) 0.370 1 0.89 (0.70-1.14) 0.368 1 0.87 (0.55-1.39) 0.564 1 0.90 (0.67-1.21) 0.489 1 
rs6277 DRD2 1.00 (0.79-1.27) 0.987 1 1.00 (0.79-1.27) 0.985 1 1.15 (0.74-1.80) 0.534 1 0.95 (0.71-1.25) 0.694 1 
rs1121980 FTO 1.11 (0.87-1.42) 0.387 1 1.11 (0.87-1.42) 0.388 1 0.68 (0.43-1.10) 0.115 0.925 1.34 (1.00-1.78) 0.047 0.632 
rs8050136 FTO 1.09 (0.85-1.39) 0.486 1 1.09 (0.85-1.39) 0.486 1 0.72 (0.44-1.16) 0.173 0.984 1.27 (0.96-1.70) 0.097 0.881 
rs9939609 FTO 1.09 (0.85-1.39) 0.499 1 1.09 (0.85-1.39) 0.499 1 0.71 (0.44-1.15) 0.161 0.977 1.27 (0.96-1.70) 0.097 0.881 
rs571312 MC4R 0.90 (0.68-1.19) 0.455 1 0.90 (0.68-0.46) 0.463 1 0.84 (0.50-1.40) 0.504 1 0.93 (0.66-1.30) 0.654 1 
rs17782313 MC4R 0.91 (0.69-1.20) 0.504 1 0.91 (0.69-1.21) 0.512 1 0.85 (0.51-1.41) 0.520 1 0.94 (0.67-1.32) 0.709 1 
rs12970134 MC4R 0.92 (0.70-1.20) 0.530 1 0.92 (0.70-1.20) 0.537 1 0.86 (0.53-1.40) 0.547 1 0.95 (0.69-1.30) 0.729 1 
rs11084753 KCTD15 1.18 (0.91-1.52) 0.219 0.991 1.18 (0.91-1.52) 0.219 0.994 1.36 (0.83-2.23) 0.217 0.995 1.11 (0.82-1.50) 0.491 1 
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rs4680 COMT 0.87 (0.68-1.11) 0.269 0.996 0.87 (0.68-1.12) 0.277 0.998 0.78 (0.48-1.26) 0.313 1 0.91 (0.68-1.21) 0.503 1 
 
1Minimally adjusted models are adjusted for sex. 2Conditional models were adjusted for age adjusted z-scores of BMI. Significant results 
(P<0.05) are marked with bold. P3 - Empirical P-value corrected for multiple testing by 1000 permutations. If significant after correction – 
underlined and marked with bold. 
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Table 5. Association between EAT-B (uncontrolled appetite/overeating sub-scale) and the weighted genetic risk scores (wGRS) in the total and 
sex stratified samples. 
Weighted GRS 
Minimally adjusted Conditional on BMI 
Outcome Sample (case, n) OR (95% CI) P OR (95% CI) P 
EAT-B All (n=152) 1.14 (0.77-1.71) 0.514 1.12 (0.74-1.68) 0.602 
Males  (n=41) 0.57 (0.27-1.18) 0.131 0.58 (0.27-1.26) 0.170 
  Females (n=111) 1.51 (0.93-2.46) 0.093 1.42 (0.87-2.32) 0.166 
EAT-B Think All (n=184) 1.23 (0.85-1.79) 0.270 1.19 (0.82-1.74) 0.362 
Males (n=41) 1.02 (0.49-2.14) 0.951 1.02 (0.48-2.17) 0.962 
Females (n=143) 1.30 (0.84-2.00) 0.238 1.23 (0.79-1.91) 0.357 
EAT-B Cont All (n=108) 1.66 (1.04-2.65) 0.034 1.62 (1.01-2.61) 0.046 
Males (n=37) 1.39 (0.64-3.05) 0.407 1.39 (0.61-3.13) 0.434 
Females (n=71) 1.81 (1.00-3.26) 0.050 1.75 (0.97-3.16) 0.063 
EAT-B Stop* All (n=270) 1.20 (0.88-1.64) 0.253 1.11 (0.81-1.53) 0.517 
Males (n=95) 1.06 (0.64-1.74) 0.832 0.95 (0.57-1.61) 0.861 
  
Females (n=175) 1.29 (0.87-1.92) 0.203 1.20 (0.81-1.80) 0.366 
Females   13-15 year (n=78) 2.21 (1.23-3.98) 0.008 2.07 (1.14-3.76) 0.017 
Females   16-19 year (n=97) 0.81 (0.47-1.41) 0.455 0.72 (0.41-1.27) 0.258 
 
The weighted GRS was calculated by multiplying the number of risk alleles at each locus (0, 1, 2) with the corresponding effect sizes per allele, 
in kg/m2 (beta), as reported by Speliotes et al. (Speliotes et al., 2010). The minimally adjusted models are adjusted for sex and age in the total 
sample and age in the sex-stratified samples. The conditional models were adjusted for sex, age and BMI in the total sample and for age and BMI 
in the sex-stratified samples. Significant results (P<0.05) are marked with bold. EAT-B sub-scale includes the following items: “When I first 
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begin eating, it is difficult to stop” (overeating, EAT-B Stop); “I spend too much time thinking about food” (food preoccupation, ETA-B Think); 
“I feel that food controls my life” (loss of control eating, EAT-B Cont). * Age group stratification due to significant sex-GRS interaction.  
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